Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day

GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States,¹ Emergent BioSolutions (NYSE: EBS) is teaming up with Voices for Awareness and Facing Fentanyl Now in honor of National Fentanyl Prevention and Awareness Day on August 21, 2025. As part of this year’s efforts, these leading advocacy organizations and its sponsors will bring their message to Times Square, NYC on the day with several high-visibility billboards that expose fentanyl risks and urge a nationwide call to action to reduce the stigma around opioid poisonings ensuring that more people can be prepared to save a life. Synthetic opioids, such as fentanyl, are a key driver of the opioid epidemic, contributing to nearly 70 percent of all overdose deaths.² Its undetectable nature—lacking taste, smell, or visible characteristics—makes fentanyl particularly dangerous, and this partnership underscores a shared commitment to saving lives through increased public awareness.

National Fentanyl Prevention and Awareness Day, observed nationwide and recognized by the U.S. Senate, serves as a critical platform to bring together families, community leaders, law enforcement, and federal agencies to combat the devastating impact of the fentanyl crisis. In memory of the countless lives lost to opioid poisonings, the day focuses on distributing life-saving naloxone, sharing vital opioid overdose prevention education and amplifying messages designed to protect communities from illicit fentanyl.

“We’re proud to sponsor Voices for Awareness and Facing Fentanyl Now on National Fentanyl Prevention and Awareness Day to help provide much-needed awareness about fentanyl risks and life-saving tools like naloxone nasal spray,” states Paul Williams, senior vice president, head of products business, global government & public affairs at Emergent. “Sadly, we are still losing far too many lives each day from opioid overdoses – this includes counterfeit pills that contain deadly fentanyl – so we must continue to educate the public on the signs of an opioid emergency and the importance of carrying naloxone.”

In light of the large number of opioid overdose fatalities in recent years,³ Emergent has remained committed to educating the public through its Ready to Rescue initiative. The campaign is focused on combating misinformation surrounding opioid poisonings and empowering the public to make the socially responsible decision to carry over-the-counter naloxone because opioid emergencies can happen to anyone, anywhere, at any time. Emergent will continue to identify pathways to expand access to multiple forms of naloxone, including over-the-counter NARCAN Nasal Spray 4 mg and prescription KLOXXADO Nasal Spray 8 mg to help ensure that every state, business, university and household is prepared to save a life.

Schreibe Deinen Kommentar